GlassScriptPhysician profile
Shiloh A Simons
NPI 1447387279
$5,248.09
in general payments reported to CMS, 2019-2025
24 companies · $1,300 in 2025
The $1,300 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.96 · 2020: $459 · 2021: $294 · 2022: $1,006 · 2023: $1,179 · 2024: $999 · 2025: $1,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,477.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,309.41 | 2019-2025 | Clareon, Wavelight Refractive Suite, Wavelight Ex500 Excimer Laser |
| Bausch & Lomb Americas INC. | $804.59 | 2022-2025 | Envista Envy Iol, Miebo, Xiidra |
| Glaukos Corporation | $766.03 | 2020-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idose, Idosetr |
| Amgen INC. | $371.71 | 2024-2025 | Tepezza |
| Abbvie INC. | $327.48 | 2022-2025 | Vuity, Alphagan P, Lumigan |
| Horizon Therapeutics Plc | $325.65 | 2022-2023 | Tepezza |
| Sight Sciences, INC. | $192.88 | 2020-2025 | Omni Surgical System |
| Oyster Point Pharma, INC. | $159.63 | 2022-2025 | Tyrvaya, Ryzumvi |
| Allergan, INC. | $113.15 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $110.85 | 2020-2023 | |
| Ocular Therapeutix, INC. | $90.55 | 2020-2023 | Dextenza |
| Johnson & Johnson Surgical Vision, INC. | $89.47 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $85.81 | 2020-2022 | |
| Thea Pharma INC. | $79.45 | 2022-2024 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $71.41 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $70.56 | 2023 | Acthar |
| Tarsus Pharmaceuticals, INC. | $59.89 | 2025 | Xdemvy |
| Rxsight INC | $58.31 | 2022-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| New World Medical,INC. | $55.71 | 2023 | |
| Dompe US, INC. | $31.40 | 2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $24.15 | 2020 | |
| Harrow Eye, LLC | $23.54 | 2023 | Iheezo |
| Ivantis, INC | $18.96 | 2020 | |
| Tearlab Corp | $7.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shiloh Simons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.